Ipsen SA (IPN)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

€100.50

Buy

€102.60

arrow-up€2.15 (+2.15%)

Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.
Prices updated at 30 Apr 2025, 16:35 CEST
| Prices minimum 15 mins delay
|
Prices in EUR
FTSE EuroFirst 300
arrow-down-0.05%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Profit margins

Created with Highcharts 7.2.2Gross margin (%)Operating margin (%)EBITDA margin (%)Net margin (%)202020212022202320240255075100

Valuation

Created with Highcharts 7.2.2Price earningsPrice / SalesPrice / Cash flow202120222023202420250102030

Profit margins data table

YearGross margin (%)Operating margin (%)Net margin (%)EBITDA margin (%)EBITDA
202482.6919.259.6832.991,179m
202382.7218.4919.4930.451,007m
202283.2827.6020.5534.001,073m
202184.0431.0523.5238.541,059m
202081.7426.9620.4029.58795m
201981.8824.62-1.885.69153m
201880.6623.6916.5927.54647m
201780.8319.9413.5424.24488m
201678.9920.9113.5220.58344m

Valuation data table

YearPrice / SalesPrice earningsPrice / Cash flow
20252.3823.919.30
20242.6913.9210.25
20232.7322.079.22
20222.6111.368.52
20212.4110.758.05
20202.10-7.78
20192.6216.2611.89
20184.3327.3218.67
20174.4938.0026.04
20163.6124.4517.84
20153.5536.0922.08
Price/Forward earnings (YTD)
10.09

Returns

Created with Highcharts 7.2.2Return on assets (%)Return on equity (%)Return on invested capital (%)202020212022202320240102030

Debt profile

Created with Highcharts 7.2.2Financial leverage2020202120222023202400.511.522.5

Returns data table

YearReturn on assets (%)Return on equity (%)Return on invested capital (%)
20245.428.648.64
202310.8017.9816.56
202212.2321.3418.25
202113.9026.5720.70
202012.7128.2319.64
2019-1.32-2.82-1.25
201812.0823.1419.41
20179.9118.8815.71
201610.3617.5015.87

Debt profile data table

YearFinancial leverage
20241.54
20231.65
20221.68
20211.82
20202.02
20192.46
20181.83
20172.01
20161.78
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.